Global research report. Vision & Reality 6th Edition

Blumstein, Jessica S. et. al., (2007)

Studie von Capgemini zur Fragestellung, wie eine frühe Kommerzialisierung von Produkten im Bereich Life Sciences realisiert werden kann. Hierzu wurden ca. 200 Manager von Life Sciences Unternehmen befragt. Capgemini surveyed 200 life sciences executives to assess how, and how well, early commercialization is working. We also conducted 45 in-depth interviews to investigate the following: • the efficacy of early commercialization efforts to date • the benefits of collaboration between Commercial and R&D functions • the limitations and challenges of this collaboration • the risks of an overly commercial focus on the long-term viability of the R&D portfolio

Referenz : http://www.de.capgemini.com/m/de/tl/Global_research_report__br___Vision___Reality_6th_Edition.pdf

Organisation : Capgemini Deutschland GmbH

Zusätzliche Daten : From Market to Discovery and back… The Value of Early Commercialization - LifeSciences